Ethos Technologies Inc. filings document its reporting as a Nasdaq-listed life insurance technology company with Class A common stock registered under the Exchange Act. Its 8-K reports furnish quarterly and annual operating results, including revenue by direct and third-party channels, profitability measures, cash flow, per-share results and policy activation metrics.
The filings also identify exhibit-based earnings releases, Inline XBRL cover-page data, securities registration details and financial-statement exhibit items. These disclosures describe Ethos' capital-market status, revenue model, product-distribution channels and recurring public-company reporting obligations.
Ethos Technologies Inc. President and director Lingke Wang converted 118,333 Class B shares into Class A shares on October 15, 2026. He also reported three sales of Class A shares that day: 22,669 at a weighted-average price of $37.64, 94,864 at $38.52, and 800 at $39.14. The reported direct Class B position following the conversion was 3,692,950 shares.
The sales were made under a Rule 10b5-1 trading plan Wang adopted on May 20, 2026, pursuant to pre-established terms rather than a discretionary decision to sell at that time. The reported trade-price ranges were $37.02 to $38.015, $38.02 to $39.01, and $39.13 to $39.145, respectively; each range is inclusive.
Ethos Technologies Inc. (LIFE) CEO and Secretary Peter George Colis converted 40,000 Class B shares into 40,000 Class A shares on each of October 14, 2026, October 15, 2026, and October 16, 2026, and sold 120,000 Class A shares across those dates. The sales were made under a Rule 10b5-1 trading plan adopted May 12, 2026, and followed its pre-established terms. The reported weighted-average sale prices for separate tranches were $38.94 and $39.58 on October 14; $37.64, $38.52, and $39.12 on October 15; and $37.68 and $38.32 on October 16.
The report also lists 28,249 Class A shares held by the Colis Zhan Family Trust, of which Colis is a trustee. It lists two trust-held Class B positions convertible into 128,893 and 214,822 underlying Class A shares; the named trustees are John N. Colis for the Peter G. Colis Family Trust and Cresset Trust Company for PGC Beta Trust, respectively.
Ethos Technologies Inc. (LIFE) is named as issuer in a Rule 144 notice for Peter George Colis's proposed sale of 40,000 common shares through Charles Schwab & Co., Inc. The listed aggregate market value is $1,510,821.00, and the approximate sale date is October 16, 2026. The notice also lists nine prior sales from August 17 through October 15, 2026.
Ethos Technologies Inc. (LIFE) lists a proposed sale of 118,333 common shares by Lingke Wang, with an approximate sale date of October 15, 2026. Charles Schwab & Co., Inc. is listed as the broker, and the stated aggregate market value is $4,538,545.
Three sales by Lingke Wang during the preceding three months are also listed: 22,623 shares on August 17, 2026, with a reported amount of $775,684; 118,333 shares on August 20, with $3,939,946; and 118,333 shares on September 17, with $4,610,321. The shares listed for sale were acquired and paid for between July 5, 2016 and May 15, 2026.
Ethos Technologies Inc. (LIFE) reports that Peter George Colis intends to sell 40,000 common shares on October 15, 2026, through Charles Schwab & Co., Inc. The proposed sale is listed at an aggregate market value of $1,533,811.00. The shares are shown as acquired on March 29, 2021, through an “Exercise and Hold” transaction.
Ethos Technologies Inc. reports Peter George Colis’s proposed sale of 40,000 common shares, with an aggregate market value of $1,562,802. The approximate sale date is October 14, 2026, through Charles Schwab & Co., Inc.
Ethos Technologies Inc. (LIFE) updated beneficial ownership information for its Class A and Class B common stock as of September 30, 2026, in connection with the December 2026 reconstitution of the Russell indices.
Shares outstanding on September 30, 2026, were 41,714,064 Class A shares and 23,269,929 Class B shares. The table lists current executive officers and directors as a group as beneficially owning 1,195,733 Class A shares and 17,341,174 Class B shares, representing 68.6% of total voting power. Ethos says index eligibility may be calculated differently and gives no assurance that its shares will be included in any indices.
Ethos Technologies Inc. (LIFE) has a Form 144 notice filed for the potential sale of 23,333 shares of common stock held at Charles Schwab & Co., Inc. by stockholder Peter George Colis. The shares were acquired on March 29, 2021 through an “Exercise and Hold” transaction.
The notice also lists multiple sales of Ethos Technologies Inc. common stock by Peter George Colis over the prior three months, with individual transactions ranging from 23,333 to 29,342 shares and aggregate dollar amounts of up to $1,003,001 per transaction.
Ethos Technologies Inc. (LIFE) director and President Wang Lingke reported transactions on September 17, 2026 involving a conversion and sales of company stock. Wang converted 118,333 shares of Class B Common Stock into the same number of Class A Common Stock and then sold 118,333 Class A shares in multiple transactions at weighted average prices around the high‑$30 range. After the conversion, Wang held 3,811,283 Class B shares directly, and additional Class B shares are held indirectly through a spouse and several 2024 trusts. The reported sales were made under a Rule 10b5-1 trading plan adopted on May 20, 2026.
Ethos Technologies Inc. (LIFE) reports that CEO and Secretary Peter George Colis converted Class B Common Stock into an equal number of Class A shares and sold 70,000 Class A shares between September 16 and 18, 2026 at weighted-average prices in the mid-to-high $30s.
The conversions and sales were made pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2026. Colis continues to have indirect interests through family trusts, including Class B shares convertible into Class A and 28,249 Class A shares held by the Colis Zhan Family Trust.